article thumbnail

FDA $7bn plans for 2024: disclose contract manufacturers, restart Cancer Moonshot

Pharmaceutical Technology

The US FDA has revealed its detailed budget proposal for FY2024, which would require pharma companies to name their active pharmaceutical ingredient (API) suppliers, restart President Biden’s Cancer Moonshot, inject cash into amyotrophic lateral sclerosis (ALS) research, and enforce stricter rules around manufacturing, recalls, and shortages.

article thumbnail

Samsung Biologics extends Bristol Myers Squibb manufacturing pact

BioPharma Reporter

The big pharma company Bristol Myers Squibb (BMS) has recruited contract manufacturing and development organization (CDMO) Samsung Biologics to manufacture a commercial antibody cancer treatment until 2030.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Brazil: untapped market for big pharma manufacturing

Pharmaceutical Technology

Only a limited number of international pharma companies, however, operate manufacturing sites in the country. Large Brazilian pharma companies already play a major role in distributing Covid-19 vaccines to all of Latin America. French and Italian manufacturers have two companies in Brazil.

article thumbnail

Russia’s focus on domestic pharma production could shield it from sanctions’ effects

Pharmaceutical Technology

Although medicines tend to be excluded from trade sanctions as they cause loss of life, Russian pharma companies may struggle to secure funding in the face of economic sanctions and there may also be a disruption to non-essential medicines. million vaccine doses upon EMA authorisation.